Effect of Vitamin D Treatment in Primary Hyperparathyroidism

• Status: Completed
• Trial end date: 2013-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The primary aim of the study is to assess whether 6-months of vitamin D supplements can decrease PTH compared with placebo treatment in primary hyperparathyroidism.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Aarhus
• Treatments: Cholecalciferol; Ergocalciferols; Vitamin D; Vitamins

Criteria

Inclusion Criteria:

• P-Ca-ion > 1,30 mmol/l

• P-PTH > 5 pmol/l

• P-OH25-vitamin D < 80 nmol/l

Exclusion Criteria:

• P-creatinin > 120 mumol/l

• usage of Etalpha, Mimpara

• Cancer

• Sarcoidosis

• malabsorption

• pancreatitis

• alcohol abuse

• pregnancy